These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28329511)

  • 1. An update in drug-induced subacute cutaneous lupus erythematosus.
    Michaelis TC; Sontheimer RD; Lowe GC
    Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of drug-induced subacute cutaneous lupus erythematosus.
    Lowe GC; Henderson CL; Grau RH; Hansen CB; Sontheimer RD
    Br J Dermatol; 2011 Mar; 164(3):465-72. PubMed ID: 21039412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced cutaneous lupus erythematosus: 88 new cases.
    Laurinaviciene R; Sandholdt LH; Bygum A
    Eur J Dermatol; 2017 Feb; 27(1):28-33. PubMed ID: 27799135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K; Booken N; Goerdt S; Goebeler M
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.
    Grönhagen CM; Fored CM; Linder M; Granath F; Nyberg F
    Br J Dermatol; 2012 Aug; 167(2):296-305. PubMed ID: 22458771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Bonsmann G; Schiller M; Luger TA; Ständer S
    J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Hivnor CM; Hudkins ML; Bonner B
    Cutis; 2008 Feb; 81(2):156-7. PubMed ID: 18441768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced subacute cutaneous lupus erythematosus: repeated occurrence following treatment with terbinafine].
    Wagner G; Sachse MM
    Hautarzt; 2014 Jun; 65(6):548-52. PubMed ID: 24452843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subacute cutaneous lupus erythematosus induced by terbinafine].
    Amitay-Layish I; Feuerman H; David M
    Harefuah; 2006 Jul; 145(7):480-2, 552. PubMed ID: 16900733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Terbinafine-induced subacute cutaneous lupus erythematosus. Case report and review of the literature].
    Matthes T; Hagedorn M
    Hautarzt; 2004 Jul; 55(7):653-7. PubMed ID: 15146276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced subacute cutaneous lupus erythematosus.
    Callen JP
    Lupus; 2010 Aug; 19(9):1107-11. PubMed ID: 20693204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM; John LH; Buckley DA
    Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes.
    Poh YJ; Alrashid A; Sangle SR; Higgins E; Benton E; McGibbon D; D'Cruz DP
    Lupus; 2022 Aug; 31(9):1078-1083. PubMed ID: 35635045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.
    Deng Z; Guo A; Wu C; Wang C
    J Cosmet Dermatol; 2022 Dec; 21(12):7202-7208. PubMed ID: 36214602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When drugs induce cutaneous lupus erythematosus].
    Skovmøller KB; Bygum A
    Ugeskr Laeger; 2018 Oct; 180(41):. PubMed ID: 30327081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.
    Sontheimer RD; Henderson CL; Grau RH
    Arch Dermatol Res; 2009 Jan; 301(1):65-70. PubMed ID: 18797894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.